3 min read
|
Saved February 14, 2026
|
Copied!
Do you care about this?
zerohash europe has gained authorization from the Dutch Authority for the Financial Markets to offer regulated crypto-asset and stablecoin services across the European Economic Area. This allows financial institutions to integrate crypto services through a single API while ensuring compliance with EU regulations.
If you do, here's more
zerohash europe has secured authorization under the EU's Markets in Crypto-Assets Regulation (MiCAR) from the Dutch Authority for the Financial Markets (AFM). This allows the company to provide regulated crypto-asset and stablecoin infrastructure services throughout the European Economic Area (EEA). The authorization specifically permits zerohash to offer B2B2C embedded services to clients, positioning the company as a key player in facilitating stablecoin transactions and crypto services for financial institutions like banks and payment platforms.
Founded in 2017, zerohash has built a robust client base that includes major firms such as Interactive Brokers, Morgan Stanley, and Stripe. The company's infrastructure enables these institutions to integrate crypto and stablecoin products via a single API-first framework, simplifying compliance and technology challenges. The customer custody for crypto-assets is secured through a segregated trust, ensuring bankruptcy protection. This European license complements zerohash's existing regulatory presence in regions like the U.S., Bermuda, and Australia.
Earlier this year, zerohash raised $104 million in a Series D-2 funding round, attracting investments from notable partners including Interactive Brokers and Morgan Stanley. The company aims to capitalize on the momentum generated by Europe's regulatory framework, which is fostering increased interest in stablecoins and tokenization among banks and fintechs. The CEO, Edward Woodford, emphasized the mission to safely make digital assets more accessible, viewing blockchain technology as essential for future financial systems in Europe.
Questions about this article
No questions yet.